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ABSTRACT
Objectives: Abdominal obesity is a risk factor for endometrial cancer. The negative impact of individual parameters of 
obesity on the procedural effects of endometrial cancer surgical treatment has been suggested. The aim of the current 
study was to estimate the relationship of particular parameters of obesity and in-hospital outcomes in patients treated 
surgically due to endometrial cancer.
Material and methods: The study included 70 women treated surgically for endometrial cancer. Pre-operatively, mass, 
body mass index (BMI), waist circumference, waist-hip ratio and selected anatomical indices were measured. The dura-
tion of surgery, hospitalisation, and the loss of haemoglobin served as parameters of in-hospital procedure success. Also, 
procedural-related complications were estimated.
Results: There were 37 (52.8%) obese females in the current study. They were obese patients presenting more advanced 
clinical stages of endometrial cancer before operation. The duration of operation (94.9 ± 21.6 min. vs. 76.1 ± 13.5 min., 
p < 0.0001), hospitalisation (12.4 ± 3.4 days vs. 10 ± 2.3 days, p = 0.0009) and haemoglobin loss (2.5 ± 0.9 g/dL vs. 1.9 ± 0.8 g/dL, 
p = 0.004) were significantly greater in obese patients. Multivariate analysis, among the independent predictors of the 
duration of operation, has confirmed the correlation between BMI, waist circumference and weight and the duration of 
hospitalisation. Waist and hip circumference and BMI coupled with external conjugate dimension and intertrochanteric 
distance have been linked with haemoglobin loss. The strongest correlation for the duration of operation, hospitalisation 
and haemoglobin loss was noticed for waist circumference (r = 0.7, r = 0.57 and r = 0.59).
Conclusions: Waist circumference and BMI are strong predictors of in-hospital outcomes among patients with endometrial 
cancer treated via traditional surgical operation.
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INTRODUCTION
Endometrial cancer is the most common cancer of 
the female reproductive organs. It is ranked fourth in 
terms of the incidence of malignant tumours. In the years 
1963–2008, a significant increase in the incidence of ma-
lignant neoplasms of endometrial cancer was observed 
(1,023 and 4,820 cases, respectively, in 1963 and 2008) [1]. 
There was also an increase in the percentage of malignant 
tumours in this organ among all malignancies in women 
from 5.3% to 7.4%. The standardised incidence rate in 
1963 and 2008 was 5.9 and 14.4 per 100,000 women, 
respectively. According to Bidziński, it is likely that the 
growing trend in the incidence of malignant neoplasms 
of the uterus will persist [1]. On the other hand, mortality 
from endometrial malignancies in the last decades has sig-
nificantly decreased. Standard mortality rates in 1963 and 
2003 were 9.1 and 2.2, respectively [1]. The occurrence 
of endometrial cancer is associated with economic and 
cultural fluctuations in developed countries that bring 
about lifestyle changes, which, among others, involve 
obesity, diabetes, hypertension, metabolic syndrome, 
multiparity, treatment with exogenous oestrogens unbal-
anced with gestagens or treatment with tamoxifen [2, 3]. 
The prolonged life expectancy in women in Poland and 
other European countries also contributes to an increase 
in the incidence of endometrial cancer. Most cases occur 
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in postmenopausal women (75%) [1]. Obesity in women 
aged 50–59 is the most important risk factor for the devel-
opment of endometrial cancer [2]. It was estimated that 
an increase in body mass by 10 kg in women in this age 
range results in a threefold higher risk of disease, an in-
crease in mass above 20 kg increases the likelihood of the 
disease even tenfold [4]. In a meta-analysis of 19 reviews 
and prospective studies, Renehan et al. [5] also found that 
each increase in BMI by 5 kg/m2 significantly increased 
a woman’s risk of developing endometrial cancer (RR 1.59, 
95% CI 1.50–1.68). Not only does obesity have impact on 
cancer-related death, but through its association with 
co-morbidities (diabetes mellitus and hypertension), it 
significantly effects all-cause mortality. The Gynaecologic 
Oncology Group, in a review among 380 patients with 
endometrial cancer, found that morbid obesity was as-
sociated with higher mortality (HR 2.77, 95% CI 1.21–6.36) 
from causes other than endometrial cancer or disease 
recurrence [6]. Endometrial cancer is not a homogene-
ous tumour, both in terms of histological structure or 
clinical exponents. Classically, according to Bokhman, two 
types of histopathology are distinguished: Type 1 — more 
frequent, endometriotic cancer, Type 2 — less frequent, 
non-endometroid cancer. Non-endometroid carcinomas 
include serous and clear cell carcinomas. The second type 
of endometrial tumours has a vague etiology and worse 
prognostics [7, 8]. Type 1 is etiopathogenetically associ-
ated with excessive oestrogen stimulation and obesity 
[9]. We assume that in about 80% of endometrial cancers, 
it is reasonable to find these compounds. According to 
the World Cancer Report, obesity accounts for 40% of 
all endometrial cancer cases [2]. Obesity is an important 
social and health problem. It is estimated that the issue 
of overweight and obesity affects 50–65% of the Euro-
pean population. In summary, there are discrepancies in 
the assessment of the influence of obesity regarding the 
course of surgically treating endometrial cancer due to 
the use of various parameters of obesity in the literature.
The aim of the current study was to assess the relation-
ship between obesity parameters and procedural indices 
with emphasis on the duration of operation, hospitalisation 
and haemoglobin loss after the operation.
MATERIAL AND METHODS
70 patients treated at the Clinical Department of Gy-
naecology of the Provincial Specialist Hospital due to en-
dometrial cancer in the period from February to August 
2011. The study included patients qualified for transab-
dominal hysterectomy with diagnosed endometrial cancer 
based on histopathological examination of uterine scrap-
ings. The research project was an observational prospective 
study of standard treatment. Before the operation, a clinical 
interview was performed. This included age, births, educa-
tion in years, prior abdominal surgeries and comorbidi-
ties. In the preoperative study, the following parameters 
were determined: height, weight, waist and hip circum-
ference in cm with a measuring tape, pelvic bone dimen-
sions using a pelvis meter. Also, body mass index (BMI) and 
waist-hip ratio (WHR) were calculated in the study group. 
According to the World Health Organization, overweight 
and individual degrees of obesity are determined by de-
fined ranges of BMI. Overweight was defined as BMI in 
the range 25–30 kg/m2. Class I obesity is within the range 
30–35 kg/m2, while class II obesity is within the range of 
35–40 and class III obesity values are > 40 kg/m2. Patients 
were qualified for the hysterectomy procedure according 
to the current Polish guidelines [10]. In the current study 
obesity was defined as the BMI ≥ 30 kg/m2. The surgery treat-
ment included: removal of the uterus with adnexal tracts, 
systemic pelvic and para-aortic lymphadenectomy(FIGO 
I–G1/G2 and myometrium invasion > 50%, G3) removal of 
the greater omentum (Excision of the greater omentum in 
serous endometrial carcinoma and sarcocarcinoma) [11]. 
In the perioperative period, selected parameters were moni-
tored and they were recognised as indicators of in-hospital 
outcome of operational treatment: the duration of surgery 
(minutes), the loss of haemoglobin — the difference in the 
serum concentration before surgery and on the second day 
after surgery (g/dL), the occurrence of procedural-related 
complications, and the duration of hospitalisation (days). 
The study has been approved by the local University of 
Rzeszów ethics committee. The protocol complied with the 
Declaration of Helsinki, and all participants provided written 
informed consent before enrolment.
Statistical analysis
Continuous variables are expressed as mean ± standard 
deviation. Categorical variables are introduced as num-
bers and percentages. Normality was assessed with the 
Shapiro-Wilk test. The Mann-Whitney U test was used for 
non-normally distributed continuous variables. Univariate 
and multivariate regression analysis were used to find sig-
nificant predictors of in-hospital outcomes. The analysed 
procedural indices (duration of operation, duration of hospi-
talization and the extent of hemoglobin loss) were assessed 
as continuous variables. Also predictors of clinical outcomes 
were assessed as continuous variables or dychotomic when 
appropriate. Multifactorial analysis was performed by back-
ward elimination. Also, Spearman’s correlations were calcu-
lated for possible relationships between selected factors 
and pre-specified indicators of in-hospital outcomes. The 
p-value < 0.05 was considered statistically significant. All 
analyses were performed with JMP®, Version 13.1.0 (SAS 
Institute INC., Cary, NC, USA).
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RESULTS
General characteristics
The patients’ epidemiology and tumour characteristics 
are presented in Table 1. In the studied group, 81.43% pre-
sented a BMI > 25 kg/m2 (Fig. 1). While 37 patients presented 
with BMI > 30 kg/m2 (52.8%). Most often, the patients were 
diagnosed and operated in stage I of the cancer according 
to FIGO — Table 2. In the preliminary analysis of the results 
of surgical treatment, we observed that the average dura-
tion of abdominal hysterectomy due to endometrial cancer 
was 86 ± 20.4 minutes, the average duration of hospitalisa-
tion was 11.3 ± 3.1 days, the average loss of haemoglobin 
measured as a difference measured in g/dL before surgery 
and on the second day after surgery was 2.2 ± 0.9 (Tab. 3).
The duration of the operation
The duration of the operation was significantly longer 
in patients with BMI value ≥ 30 kg/m2 compared patients 
with BMI value < 30 kg/m2 (94.9 ± 21.6 vs. 76.1 ± 13.5 days, 
p < 0.0001). The duration of operation time correlated 
positively with body mass, BMI value, hip circumference, 
WHR, intertrochanteric distance, interspinous distance, 
intercristal distance, external conjugate and prior abdomi-
nal surgery, while a negative correlation was found with 
Table 1. Patients epidemiology and tumour characteristics
Variable Overal group N = 70 (%)
Place of residence
Rural region 26 (37.2)
Urban region 24 (34.3)
Town > 50,000 residents 20 (28.5)
Menstrual status
Before menopause 61 (87.1)
After menopause 9 (12.9)
Parity
Nulliparous 14 (20.1)
Uniparous 16 (22.8)
Multiparous 40 (57.1)
Histopathological type
Endometrioid
G1 36 (51.4)
G2 24 (34.2)
G3 5 (7.1)
Clear-cell 1 (1.4)
Serous 2 (2.8)
Adenosquamous 1 (1.4)
Non-epithelial 1 (1.4)
Staging according to FIGO classification
I 52 (74.3)
II 11 (14.3)
III 5 (7.1)
IV 2 (2.8)
Co-morbidities
Diabetes mellitus 17 (24.8)
Hypertension 32 (54.8)
Coronary artery disease 5 (7)
History of venous occlusive disease 3 (5.2)
Arrhythmias 6 (8.4)
Priorcerebral stroke 2 (2.8)
Chronic heart failure 4 (5.6)
Bronchial asthma 5 (7)
Chronic pulmonary obstructive disease 3 (4.2)
Hyperthyroidism 4 (5.6)
Hypothyroidism 3 (4.2)
Cholelithiasis 6 (8.4)
Diathesisurica 2 (2.8)
Osteoarthritis 9 (12.6)
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the number of births. This is presented in Table 4. Univari-
ate regression analysis confirmed significant relationships 
between operation duration and body mass, BMI, waist 
circumference, hip circumference, WHR, intertrochanteric 
distance, interspinous distance, intercristal distance, prior 
abdominal surgery, hypertension, diabetes, chronic ob-
structive pulmonary disease and hypothyroidism. This 
is presented in Table 5. Multivariate regression analysis 
among the above-mentioned factors confirmed significant 
relationships between the duration of the operation and 
waist circumference (p < 0.0001), body mass (p < 0.0001), 
chronic obstructive pulmonary disease (p = 0.001), BMI 
(p = 0.0002), intertrochanteric distance (p = 0.01) and 
hypothyroidism (p = 0.02).
The duration of hospitalisation
The mean duration of hospitalisation was significantly 
longer in patients with BMI value ≥ 30 kg/m2 compared to 
those with BMI value < 30 kg/m2 (12.4 ± 3.4 vs. 10 ± 2.3 days, 
p = 0.0009; Tab. 3). The duration of hospitalisation correlated 
significantly positively with body mass, BMI, waist circumfer-
ence, hip circumference, WHR, , intertrochanteric distance, 
interspinous distance, intercristal dimension, external con-
Table 2. Clinical stages according to International Federation of Gynaecology and Obstetrics (FIGO) 2008 — comparison of the number of patients 
in each stage of cervical cancer depending on the presence of obesity (Chi square test)
Stages of severity Overall groupN = 70
Obese
(BMI ≥ 30 kg/m2)
N = 37
Non-obese
(BMI < 30 kg/m2)
N = 33
p value
Stage I
A
B
34 (51.4)
16 (22.8)
15 (40.6)
8 (21.6)
19 (57.4)
9 (27.2)
0.15
0.58
Stage II 11 (14.3) 5 (13.5) 5 (15.4) 0.84
Stage III
A
B
C1
C2
5 (7.1)
1 (1.4)
1 (1.4)
0
5 (13.5)
1 (2.7)
1 (2.7)
0
0
0
0
0
–
–
–
–
Stage IV
A
B
0
2 (2.8)
0
2 (5.4)
0
0
–
–
BMI — body mass index
Table 3. Comparison of selected indices in obese and non-obese patients
Overall group Obese (BMI ≥ 30 kg/m2) Non-obese (BMI < 30 kg/m2) p value
Age, years 61.3 ± 10.4 63.3 ± 9 59.1 ± 11.5 0.09
Intertrochromatic dimension, cm 35.3 ± 2.1 36.2 ± 2 34.2 ± 1.8 < 0.0001
Intersubular dimension, cm 26.9 ± 2 27.6 ± 2.1 26.2 ± 1.7 0.0006
Intercristal distance, cm 32.3 ± 3 33.7 ± 2.5 30.7 ± 2.7 < 0.0001
External conjugate, cm 22.2 ± 1.5 22.8 ± 1.4 21.5 ± 1.4 0.0002
Duration of operation, minutes 86 ± 20.4 94.9 ± 21.6 76.1 ± 13.5 < 0.0001
Duration of hospitalisation, days 11.3 ± 3.1 12.4 ± 3.4 10 ± 2.3 0.0009
Loss of haemoglobin, g/dL 2.2 ± 0.9 2.5 ± 0.9 1.9 ± 0.8 0.004
BMI — body mass index
 Figure 1. Patient distribution according to body mass index (BMI) 
value; BMI — body mass index
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jugate, prior abdominal surgery, clinical stages according 
to FIGO classification and histopatological grading. This 
is presented in Table 4. Univariate regression analysis also 
revealed significant relationships between the duration 
of hospitalisation and body mass, BMI, waist circumfer-
ence, hip circumference, WHR, intertrochanteric distance, 
interspinous distance, external conjugate prior abdominal 
surgery, hypertension, diabetes, chronic obstructive pul-
monary disease, hypothyroidism and heart failure. This is 
presented in Table 5. Multivariate regression analysis among 
the above-mentioned factors confirmed that the duration 
of hospitalisation was significantly associated with waist 
circumference, hip circumference, prior abdominal surgery 
hypothyroidism and BMI.
Table 4. Significant correlations between selected indices and haemoglobin loss during operation, duration of operation and hospitalisation
Predictors
∆ Hb before and two days 
after operation [g/dL] Duration of operation [min.]
Duration of hospitalisation 
[days]
R coefficient p value R coefficient p value R coefficient p value
Weight, kg 0.54 < 0.0001 0.59 < 0.0001 0.48 < 0.0001
Body-mass index, kg/m2 0.55 < 0.0001 0.57 < 0.0001 0.48 < 0.0001
Waist circumference, cm 0.57 < 0.0001 0.7 < 0.0001 0.59 < 0.0001
Hip circumference, cm 0.46 < 0.0001 0.57 < 0.0001 0.43 0.0002
Waist-hip ratio 0.42 0.0003 0.36 0.002 0.35 0.003
Intertrochromatic dimension, cm 0.33 0.004 0.45 0.001 0.25 0.03
Intersubular dimension, cm – – 0.36 0.002 0.31 0.008
Intercristal distance, cm 0.43 0.0002 0.39 0.0007 0.25 0.03
External conjugate, cm 0.48 < 0.0001 0.28 0.02 0.33 0.004
Prior abdominal surgery 0.42 0.0003 0.29 0.014 0.41 0.0005
Number of births – – –0.28 0.017 – –
Clinical stages, FIGO 0.29 0.01 – – 0.24 0.04
Histopathology, grading – – – – 0.25 0.04
∆ Hb — the difference in the serum concentration before surgery and on the second day after surgery
Table 5. Predictors of blood loss, duration of operation and hospitalisation assessed by univariate regression analysis
Predictors
∆ Hb before and two days after 
operation [g/dL]
Duration of operation
[min.]
Duration of hospitalisation 
[days]
ß (95% CI) p value ß (95% CI) p value ß (95% CI) p value
Weight, kg 0.018 (0.008–0.028 0.00006 0.641 (0.439–0.842) < 0.0001 0.081 (0.048–0.115) < 0.0001
Body-mass index, kg/m2 0.043 (0.018–0.068) 0.001 1.554 (1.061–2.048) < 0.0001 0.205 (0.124–0.286) 0.0009
Waist circumference, cm 0.02 (0.01–0.031) 0.0002 0.759 (0.564–0.955) < 0.0001 0.102 (0.069–0.135) < 0.0001
Hip circumference, cm 0.018 (0.005–0.032) 0.005 0.681 (0.408–0.954) < 0.0001 0.082 (0.037–0.126) 0.0005
Waist-hip ratio 4.123 (1.605–6.64) 0.002 102.39 (45.27–159.5) 0.0006 15.55 (6.784–24.33) 0.0007
Intertrochromatic dimension, cm – – 3.929 (1.833–6.024) 0.0004 0.424 (0.086–0.761) 0.014
Intersubular dimension, cm – – – – 0.397 (0.042–0.753) 0.028
Intercristal distance, cm 0.082 (0.013–0.151) 0.02 2.341 (0.793–3.89) 0.004 – –
External conjugate, cm 0.273 (0.15–0.396) < 0.0001 – – 0.534 (0.059–1.009) 0.028
Prior abdominal surgery 0.361 (0.109–0.614) 0.006 7.016 (1.128–12.904) 0.02 1.461 (0.615–2.306) 0.001
Hypertension 0.246 (0.041–0.451) 0.019 7.857 (3.328–12.38) 0.0009 1.033 (0.322–1.743) 0.005
Diabetes mellitus – – 4.955 (0.192–9.718) 0.04 1.059 (0.351–1.767) 0.004
COPD – – 8.647 (1.23–16.063) 0.023 1.258 (0.116–2.399) 0.031
Hypothyroidism – – 11.86 (5.475–18.257) 0.0004 1.708 (0.716–2.7) 0.001
Heart failure – – – – 1.684 (0.282–3.086) 0.02
∆ Hb — the difference in the serum concentration before surgery and on the second day after surgery; ß — coefficient beta; CI — confidence interval; COPD — chronic 
obstructive pulmonary disease
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Procedure-related haemoglobin loss
The mean haemoglobin loss during periproce-
dural time was significantly higher in patients with BMI 
value ≥ 30 kg/m2 compared to patients with BMI val-
ue < 30 kg/m2 (2.5 ± 0.9 vs. 1.9 ± 0.8 g/dL, p = 0.004; Tab. 3). 
The degree of haemoglobin loss at the periprocedural time 
correlated significantly and positively with body mass, BMI, 
waist circumference, hip circumference, WHR, intertrochan-
teric distance, intercristal distance, external conjugate, prior 
abdominal surgery and clinical stages according to FIGO 
classification. This is presented in Table 4. Univariate regres-
sion analysis revealed significant relationships between 
periprocedural degree of haemoglobin loss and body mass, 
BMI, waist circumference, hip circumference, WHR, intercris-
tal distance, external conjugate, prior abdominal surgery 
and hypertension. This is presented in Table 5. Multivariate 
regression analysis among the above-mentioned factors 
confirmed a significant relationship between the degree 
of haemoglobin loss during periprocedural time and ex-
ternal conjugate (p = 0.0002) and prior abdominal surgery 
(p = 0.001).
Anatomical parameters
Anatomical indices were significantly higher in pa-
tients with BMI value ≥ 30 kg/m2 compared to patients 
with BMI < 30 kg/m2, and they included intertrochanteric 
distance (36.2 ± 2 vs. 34.2 ± 1.8 cm, p < 0.0001), interspinous 
distance (27.6 ± 2.1 vs. 26.2 ± 1.7 cm, p = 0.0006), intercristal 
distance (33.7 ± 2.5 vs. 30.7 ± 2.7 cm, p < 0.0001) and external 
conjugate (22.8 ± 1.4 vs. 21.5 ± 1.4 cm, p = 0.0002). This is 
presented in Table 3.
Procedure-related complications
There were 5 perioperative complications: infection 
of the postoperative wound with impaired healing in 
2 patients, intraoperative bladder injury in one patient, 
gastrointestinal obstruction in 1 case and intraoperative 
bleeding with the need to ligate the internal iliac artery in 
another patient. On average, patients with procedure-re-
lated complications showed higher obesity parameters: 
BMI (38 vs. 31.7 kg/m2, p = 0.88) and waist circumference 
(119.6 vs. 103.7 cm, p = 0.54), compared to patients who 
had no procedure-related complications, however, those 
differences did not reach statistical significance.
DISCUSSION
The main findings of the current study are that patients 
with the mean BMI value > 30 kg/m2 demonstrated longer 
duration of hospitalisation and operation, as well as greater 
haemoglobin loss during the periprocedural period. The 
second observation worth mentioning is that patients with 
obesity were diagnosed with endometrial cancer at more 
advanced stages according to the FIGO classification be-
fore the surgical treatment in comparison to non-obese 
patients. Thirdly, among predictors of the longer duration 
of operation we confirmed greater BMI, greater waist cir-
cumference and body mass. While among predictors of the 
duration of hospitalisation there were greater waist and hip 
circumference and greater BMI value. The external conjugate 
and intertrochanteric dimensions were found to be predic-
tors of greater haemoglobin loss related to the procedure. 
The strongest correlation for the duration of operation, 
hospitalisation and haemoglobin loss was noticed for waist 
circumference. Moreover, patients with procedure-related 
complications were characterised by greater BMI value 
and waist circumference. The percentage distribution of 
obesity parameters showed that a significant percentage 
of patients with normal BMI presented abdominal obesity 
in the study group according to IDF criteria. Similar results 
were obtained in a study on the prevalence of metabolic 
syndrome in the population of the Tarnawa Dolna com-
mune (70% of patients with abdominal obesity) [12]. The 
results of the study in the population of women treated for 
endometrial cancer show a higher incidence of this type of 
obesity than in the general population (> 90%). Most often, 
the patients’ operations were diagnosed at stage I according 
to the FIGO classification. The average duration of surgery 
in the study group operated on for endometrial cancer is 
comparable to the results obtained at other centres [13, 14]. 
This study, however, used other parameters of blood loss 
(blood volume), and the average length of stay in hospital 
was much shorter. The effect of visceral obesity on the re-
sults of surgical treatment has not been studied. However, 
the influence of obesity measured by the BMI parameter on 
the duration of surgery and blood loss was demonstrated, 
which was also confirmed in the presented study for both 
the BMI parameter and waist circumference. In the current 
study, the greater waist circumference value is related to 
longer duration of the operation and hospitalisation, and 
among other natural explanations of that relationship are 
greater extent, incision and more complicated surgical pro-
cedure in obese compared to non-obese patients. This also 
definitely reflects directly greater haemoglobin loss during 
the procedure and remains in close relation to the more 
advanced disease in this particular group of patients. Inter-
esting data were presented by Kerimoglu et al. [15]. Their 
study evaluated the effect of the percentage of body fat on 
surgical outcomes in women with endometrial cancer. In 
the group patients with an elevated % of body fat, a longer 
mean operation time was noted than in those with a % of 
body fat less than 32% (138.2 ± 27.1 vs. 119.3 ± 34.8 min, 
p = 0.043). Nonetheless, there were no differences between 
patient groups regarding rates of intraoperative complica-
tions, mean duration of hospital stay and postoperative 
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complications [15]. However, in a cohort of 192 patients 
with differing BMI, Jan et al. showed that surgical operative 
time and mean length of hospitalisation in days were not 
significantly different among the 4 groups. In the obese 
group, there was significantly higher perioperative blood 
loss (p = 0.01), more wound abscess (p = 0.05) and more 
reinterventions for complications (p = 0.03) [16]. The in-
cidence of postoperative complications in developed 
countries is estimated at 3–22% after surgical operations 
[11, 13, 15, 17]. Postoperative complications can be divided 
into early and late. The most common early complications 
in surgical gynaecology are: bleeding, bladder damage, 
ureters, intestinal perforation. The most frequent postop-
erative complications include infections, wound healing 
disorders, thromboembolic complications, cardiovascular 
complications, respiratory failure, gastrointestinal obstruc-
tion, renal failure, urination disorders, urogenital fistulas, 
intestinal fistulas. Co-morbidity of obesity and endome-
trial cancer may be associated with the increased rate of 
procedure-related complications. It has long been assumed 
that obesity can hinder the course of surgery. Some studies 
have shown that obesity is an obstacle to cancer staging 
in endometrial cancer [13], breast cancer [18] and gastric 
cancer [19]. A recent study identified EC patients with a body 
mass index (BMI) of ≥ 40 kg/m2 at increased risk of develop-
ing surgical complications compared to their non-obese 
counterparts [20]. However, among 514 women with en-
dometrial cancer, Bouwman et al. noted that obese and 
morbidly obese women experienced significantly more sur-
gical complications than non-obese women (p = 0.010) [21]. 
This was confirmed in the present study. 
In a prospective study conducted on a group of 233 pa-
tients operated on due to endometrial cancer, it was shown 
that the BMI value significantly and positively correlates with 
the duration of the surgery and the loss of haemoglobin 
during the periprocedural period. However, no relationships 
were found between obesity, the duration of hospitalisation 
and the occurrence of postoperative complications [14]. 
However, a study conducted in Turkey suggests that obesity 
in this group of patients does not significantly affect the 
number of acquired lymph nodes, the duration of hospi-
talisation or the number of procedure-related complica-
tions. However, this study was conducted on a relatively 
small group of 48 patients [22]. There are discrepancies in 
the literature regarding the influence of obesity on the oc-
currence of post-operative complications such as: infections, 
wound healing disorders, pulmonary embolism, and venous 
thromboembolism. Some authors mention visceral obesity 
as potentially crucial in understanding the real impact of 
obesity on the incidence of postoperative complications 
[22, 23]. On the basis of the conducted study, it could not be 
unequivocally determined whether there is a relationship 
between obesity and the occurrence of perioperative com-
plications. The comparative group of patients with complica-
tions (5 patients), despite clear differences in parameters, 
did not demonstrate statistical significance. In the current 
study, there is no consensus in the assessment of the rela-
tionship between obesity and specific postoperative com-
plications. Probably, chronic inflammation and metabolic 
disturbances observed in abdominal obesity contribute 
to postoperative complications such as: infections, wound 
healing disorders, circulatory and respiratory disorders [14]. 
In our study the highest predictive value for analysed pa-
rameters in- hospital outcomes among patients with en-
dometrial cancer were BMI value and waist circumference. 
CONCLUSIONS
Obesity predisposes to the later diagnosis of endome-
trial cancer at a more advanced stage, which may contribute 
to worse treatment results both in terms of the effectiveness 
of the procedure and mortality in the follow-up period. 
Waist circumference seems to be the most sensitive marker, 
indicating the possibility of extending the duration of the 
procedure and hospitalization, which is also associated 
with increased blood loss associated with the procedure. 
Therefore, waist circumference could serve as a tool for 
operational risk stratification. Further research will help 
determine a more accurate relationship between obesity 
and the occurrence of specific perioperative complications.
Limitations
This study can be referred to as a developmental study 
because it was conducted on a small group of patients. Also 
due to the relatively small group of patients studied, in the 
analysis we conducted, we focused on assessing trends 
and the relationship of individual indicators with treatment 
results. However, we have not attempted to isolate cut-off 
points for individual data above which the risk of losing large 
amounts of hemoglobin increases significantly.
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